146 related articles for article (PubMed ID: 25698055)
1. Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.
Bazin HG; Li Y; Khalaf JK; Mwakwari S; Livesay MT; Evans JT; Johnson DA
Bioorg Med Chem Lett; 2015 Mar; 25(6):1318-23. PubMed ID: 25698055
[TBL] [Abstract][Full Text] [Related]
2. Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
Bazin HG; Bess LS; Livesay MT; Li Y; Cybulski V; Miller SM; Johnson DA; Evans JT
Bioorg Med Chem Lett; 2020 Mar; 30(6):126984. PubMed ID: 32001135
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Toll-like Receptors 7 and 8 Agonists: Structure-Activity Relationship in the Oxoadenine Series.
Evans JT; Bess LS; Mwakwari SC; Livesay MT; Li Y; Cybulski V; Johnson DA; Bazin HG
ACS Omega; 2019 Sep; 4(13):15665-15677. PubMed ID: 31572869
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility.
Nakamura T; Wada H; Kurebayashi H; McInally T; Bonnert R; Isobe Y
Bioorg Med Chem Lett; 2013 Feb; 23(3):669-72. PubMed ID: 23265901
[TBL] [Abstract][Full Text] [Related]
5. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
7. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
[TBL] [Abstract][Full Text] [Related]
8. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
[TBL] [Abstract][Full Text] [Related]
9. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.
Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL
Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
Kurimoto A; Hashimoto K; Nakamura T; Norimura K; Ogita H; Takaku H; Bonnert R; McInally T; Wada H; Isobe Y
J Med Chem; 2010 Apr; 53(7):2964-72. PubMed ID: 20232824
[TBL] [Abstract][Full Text] [Related]
11. 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
Weterings JJ; Khan S; van der Heden van Noort GJ; Melief CJ; Overkleeft HS; van der Burg SH; Ossendorp F; van der Marel GA; Filippov DV
Bioorg Med Chem Lett; 2009 Apr; 19(8):2249-51. PubMed ID: 19299126
[TBL] [Abstract][Full Text] [Related]
12. IFNα enhances the production of IL-6 by human neutrophils activated via TLR8.
Zimmermann M; Arruda-Silva F; Bianchetto-Aguilera F; Finotti G; Calzetti F; Scapini P; Lunardi C; Cassatella MA; Tamassia N
Sci Rep; 2016 Jan; 6():19674. PubMed ID: 26790609
[TBL] [Abstract][Full Text] [Related]
13. Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines.
Hunt JR; Kleindl PA; Moulder KR; Prisinzano TE; Forrest ML
Bioorg Med Chem Lett; 2020 Jan; 30(2):126788. PubMed ID: 31784317
[TBL] [Abstract][Full Text] [Related]
14. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
16. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
17. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway.
Alper PB; Deane J; Betschart C; Buffet D; Collignon Zipfel G; Gordon P; Hampton J; Hawtin S; Ibanez M; Jiang T; Junt T; Knoepfel T; Liu B; Maginnis J; McKeever U; Michellys PY; Mutnick D; Nayak B; Niwa S; Richmond W; Rush JS; Syka P; Zhang Y; Zhu X
Bioorg Med Chem Lett; 2020 Sep; 30(17):127366. PubMed ID: 32738975
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.
Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S
Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449
[TBL] [Abstract][Full Text] [Related]
20. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
